tetano
Editor, Senior Moderator
Cureus
. 2022 May 11;14(5):e24912.
doi: 10.7759/cureus.24912. eCollection 2022 May.
Double Trouble: A Case of Two Simultaneous Thrombotic Events in a Patient With COVID-19
Alexander Landsman[SUP] 1 [/SUP], James R Pellegrini[SUP] 1 [/SUP], Muhammad S Tiwana[SUP] 1 [/SUP], Shivankshi Berry[SUP] 1 [/SUP], Jaswinder Singh[SUP] 1 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) is known to primarily have respiratory tract involvement, but thromboembolic complications can occur as well, leading to increased overall mortality seen in these patients. We present a case of a patient infected with COVID-19 who then developed two simultaneous thrombotic events. Our patient is a 57-year-old male who presented to the emergency department with sudden onset dysarthria and left lower extremity weakness. Medical records indicated he recently tested positive for COVID-19 infection 10 days ago. Magnetic resonance imaging (MRI) of the brain revealed an acute right cerebellar infarction as well as acute bilateral thalamic infarcts. Later in the hospital course, computed tomography angiography (CTA) of the chest revealed a right lower lobe segmental pulmonary artery embolism. Patients with COVID-19 have been seen to develop a wide spectrum of thromboembolic manifestations, most commonly being venous thromboembolism. Arterial thrombosis and microvascular disease can be detected as well. Early diagnosis and treatment of clotting disease is essential and may decrease overall mortality in COVID-19-infected patients.
Keywords: covid-19; hypercoagulable state; ischemic cerebrovascular disease; prophylactic anticoagulation; pulmonary embolism (pe); therapeutic anticoagulation; thromboembolic disease.
. 2022 May 11;14(5):e24912.
doi: 10.7759/cureus.24912. eCollection 2022 May.
Double Trouble: A Case of Two Simultaneous Thrombotic Events in a Patient With COVID-19
Alexander Landsman[SUP] 1 [/SUP], James R Pellegrini[SUP] 1 [/SUP], Muhammad S Tiwana[SUP] 1 [/SUP], Shivankshi Berry[SUP] 1 [/SUP], Jaswinder Singh[SUP] 1 [/SUP]
Affiliations
- PMID: 35698677
- PMCID: PMC9187138
- DOI: 10.7759/cureus.24912
Abstract
Coronavirus disease 2019 (COVID-19) is known to primarily have respiratory tract involvement, but thromboembolic complications can occur as well, leading to increased overall mortality seen in these patients. We present a case of a patient infected with COVID-19 who then developed two simultaneous thrombotic events. Our patient is a 57-year-old male who presented to the emergency department with sudden onset dysarthria and left lower extremity weakness. Medical records indicated he recently tested positive for COVID-19 infection 10 days ago. Magnetic resonance imaging (MRI) of the brain revealed an acute right cerebellar infarction as well as acute bilateral thalamic infarcts. Later in the hospital course, computed tomography angiography (CTA) of the chest revealed a right lower lobe segmental pulmonary artery embolism. Patients with COVID-19 have been seen to develop a wide spectrum of thromboembolic manifestations, most commonly being venous thromboembolism. Arterial thrombosis and microvascular disease can be detected as well. Early diagnosis and treatment of clotting disease is essential and may decrease overall mortality in COVID-19-infected patients.
Keywords: covid-19; hypercoagulable state; ischemic cerebrovascular disease; prophylactic anticoagulation; pulmonary embolism (pe); therapeutic anticoagulation; thromboembolic disease.